Építés alatt – nem éles oldal
Belépés
Fut, nem toborozFázis nélkül

Multicenter Symphony™ IL-6 Monitoring Sepsis ED Pilot Study

A legfontosabb adatok

Ki végzi
Bluejay Diagnostics, Inc.
Hol
Boston, Gainesville, Nashville, Salt Lake City és Winston-Salem (Egyesült Államok)Mind a 5 helyszín megnézése
Azonosító
Állapot
Fut, nem toboroz
Résztvevők
450 fő, tervezett
Kezdés
2026. máj. 4.
Várható befejezés
2026. dec. 30.
A vizsgálat típusa
Megfigyeléses, 3 csoport
A regiszteradat frissítve
2026. szeptember 29.

Ki vehet részt

Életkor
22 év felett
Nem
Nők és férfiak
Egészséges önkéntesek
Nem vehetnek részt

A regiszter feltételei, szó szerint

Mind a 25 feltétel megnézéseKevesebb

Ki vehet részt

  • Adult patients (≥22 years of age)
  • Intent to admit to hospital or admitted to the hospital via the emergency department
  • At least 0.6 mL plasma drawn (optimal 1 mL) and available for collection (or is anticipated to be able to be drawn and available) within 12 hours of (i.e., up to 12 hours after) presentation to the emergency department. For Cohort 1, Criterion #1 criteria should be met within 3 hours of sample collection (fresh or remnant)
  • Meets criteria for at least one of the 3 cohorts (patients may be included in more than one cohort) within 12 hours of emergency department presentation:; Cohort 1 (Systemic inflammatory response or culture ordered):
  • Criterion #1 (2 of below within 3 hours of sample collection, of which 1 is at least (A) or (B))
  • A) body temperature >38C or <36C,
  • B) HR>90 beats/min,
  • C) respiratory rate >20 breaths/min, or
  • D) white blood cell count > 12K or <4K/microliters or over 10% immature forms or bands) OR:
  • Criterion #2 (order for culture of a body fluid (e.g., blood, urine, sputum)); Cohort 2 (Treatment for suspected infection initiated):
  • Meets criteria for Cohort 1 and antimicrobials (antibiotics or antivirals) ordered; Cohort 3 (Confirmed or strong evidence of infection):
  • Meets criteria for Cohorts 1 and 2, AND 1 or more of the following criteria:
  • Temp >101F (38.3C)
  • pneumonia by x-ray or CT,
  • Urinalysis with WBC>10/HPF
  • Intraabdominal-pelvis infection by CT, U/S, or MRI
  • Skin / soft tissue infection by clinical exam
  • Evidence of meningitis on LP
  • Positive microbiological culture (cultures drawn within 3 days of presentation)
  • Suspected line infection (e.g. redness or pus around the line)

Ki nem vehet részt

  • Prior enrollment into this study
  • Prisoners or imprisonment at time of enrollment
  • Pregnant
  • Informed consent as approved by IRB is unable to be obtained
  • Environmental exposure (e.g., heat exposure)

Helyszínek itt: Egyesült Államok

  • Beth Israel Deaconess Medical CenterBoston, Egyesült Államok
  • University of Florida College of MedicineGainesville, Egyesült Államok
  • Vanderbilt University Medical CenterNashville, Egyesült Államok
  • Intermountain HealthSalt Lake City, Egyesült Államok
  • Wake Forest School of MedicineWinston-Salem, Egyesült Államok

A vizsgálatról

Mit akar kideríteni a vizsgálat

The primary objective of this study is to establish an IL-6 concentration cutoff that predicts sepsis or septic shock (according to the Third International Consensus Definitions (Sepsis-3 criteria)) in patients who are admitted or are intended to be admitted to the hospital from the emergency department with suspected infection.

A vizsgálat 3 csoportja

  • Cohort 1: Systemic inflammatory response or culture ordered

    Criterion #1: (2 of the following within 3 hours of sample collection, of which 1 is at least (A or B): A) body temp \>38c or \<36c B) HR \>90bpm C) respiratory rate \>20 breaths/min D) white blood cell count \>12k or \<4k/microliters or over 10% immature forms or bands, OR Criterion #2: order for culture of a body fluid (blood, urine, sputum)

  • Cohort 2: Treatment for suspected infection initiated

    Meets criteria for Cohort 1 and antimicrobials (antibiotics or antivirals) ordered

  • Cohort 3: Confirmed or strong evidence of infection

    Meets criteria for Cohorts 1 and 2, AND 1 or more of the following criteria: Temp \>101F (38.3c) Pneumonia by X-ray or CT Urinalysis with WBC \>10/HPF Intraabdominal-pelvis infection by CT U/S or MRI Skin/soft tissue infection by clinical exam Evidence of meningitis on LP Positive microbiological culture (cultures drawn within 3 days of presentation) Suspected line infection (e.g., redness or pus around the line)

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
A regiszteradat frissítve
2026. szeptember 29.